Regulations.gov document
Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and…
Notice · FDA-2010-N-0002 · posted Jan 29, 2010
Key facts
| Document ID | FDA-2010-N-0002-0003 |
|---|---|
| Title | Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension |
| Document type | Notice |
| Subtype | Notice of Final Rule |
| Agency | FDA |
| Docket | FDA-2010-N-0002 |
| Posted | Jan 29, 2010 |
| Federal Register citation | 75 FR 4692 |
| FR document number | 2010-01794 |
| CFR | 21 CFR 524 |
| Comment period opens | Jan 29, 2010 |
| Effective date | Jan 29, 2010 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: